title: Herpes Simplex Virus 1 Interaction with Myeloid Cells In Vivo.
abstract: Herpes simplex virus 1 (HSV-1) enters mice via olfactory epithelial cells and then colonizes the trigeminal ganglia (TG). Most TG nerve endings are subepithelial, so this colonization implies subepithelial viral spread, where myeloid cells provide an important line of defense. The outcome of infection of myeloid cells by HSV-1 in vitro depends on their differentiation state; the outcome in vivo is unknown. Epithelial HSV-1 commonly infected myeloid cells, and Cre-Lox virus marking showed nose and lung infections passing through LysM-positive (LysM(+)) and CD11c(+) cells. In contrast, subcapsular sinus macrophages (SSMs) exposed to lymph-borne HSV-1 were permissive only when type I interferon (IFN-I) signaling was blocked; normally, their infection was suppressed. Thus, the outcome of myeloid cell infection helped to determine the HSV-1 distribution: subepithelial myeloid cells provided a route of spread from the olfactory epithelium to TG neurons, while SSMs blocked systemic spread.
  
  
  
  Herpes simplex virus 1 (HSV-1) infects most people and can cause severe disease. This reflects its persistence in nerve cells that connect to the mouth, nose, eye, and face. Established infection seems impossible to clear. Therefore, we must understand how it starts. This is difficult in humans, but mice show HSV-1 entry via the nose and then spread to its preferred nerve cells. We show that this spread proceeds in part via myeloid cells, which normally function in host defense. Myeloid infection was productive in some settings but was efficiently suppressed by interferon in others. Therefore, interferon acting on myeloid cells can stop HSV-1 spread, and enhancing this defense offers a way to improve infection control.
authors.affiliation: Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Maitreyi
authors.initials: M
authors.lastname: Shivkumar
authors.affiliation: School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Australia.
authors.forename: Clara
authors.initials: C
authors.lastname: Lawler
authors.affiliation: Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Milho
authors.affiliation: Division of Virology, Department of Pathology, University of Cambridge, Cambridge, United Kingdom School of Chemistry and Molecular Biosciences, University of Queensland and Royal Children's Hospital, Brisbane, Australia p.stevenson@uq.edu.au.
authors.forename: Philip G
authors.identifier: 0000-0002-3520-5060
authors.initials: PG
authors.lastname: Stevenson
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D018259:Herpesvirus 1, Human / Q000502:physiology*; D008810:Mice, Inbred C57BL; D022423:Myeloid Cells / Q000821:virology*; D056189:Viral Tropism